We are pleased to announce xFOREST Therapeutics Co., Ltd. is established. Shunichi KASHIDA (left) will become President and CEO and Kaoru Richard KOMATSU (right) will become Chairman of the board and CTO.
About xFOREST Therapeutics
xFOREST Therapeutics Co., Ltd. is a Kyoto-based RNA-targeted small molecule company. Building on its proprietary RNA structure analysis technology, xFOREST discovers selective small molecules for RNA targets that protein-first discovery cannot reach, and advances them into drug programs with partners.